Machine learning on normalized protein sequences by Heider, Dominik et al.
SHORT REPORT Open Access
Machine learning on normalized protein
sequences
Dominik Heider
1*, Jens Verheyen
2 and Daniel Hoffmann
1
Abstract
Background: Machine learning techniques have been widely applied to biological sequences, e.g. to predict drug
resistance in HIV-1 from sequences of drug target proteins and protein functional classes. As deletions and
insertions are frequent in biological sequences, a major limitation of current methods is the inability to handle
varying sequence lengths.
Findings: We propose to normalize sequences to uniform length. To this end, we tested one linear and four
different non-linear interpolation methods for the normalization of sequence lengths of 19 classification datasets.
Classification tasks included prediction of HIV-1 drug resistance from drug target sequences and sequence-based
prediction of protein function. We applied random forests to the classification of sequences into “positive” and
“negative” samples. Statistical tests showed that the linear interpolation outperforms the non-linear interpolation
methods in most of the analyzed datasets, while in a few cases non-linear methods had a small but significant
advantage. Compared to other published methods, our prediction scheme leads to an improvement in prediction
accuracy by up to 14%.
Conclusions: We found that machine learning on sequences normalized by simple linear interpolation gave better
or at least competitive results compared to state-of-the-art procedures, and thus, is a promising alternative to
existing methods, especially for protein sequences of variable length.
Background
Statistical methods and machine learning techniques,
such as linear regression (LR) [1], decision trees (DTs)
[2], artificial neural networks (ANNs) [3], support vector
machines (SVMs) [4], and random forests (RFs) [5] have
been widely applied in biomedical pattern classification,
for instance in the prediction of HIV drug resistance
and protein function. In several studies, the amino acid
or DNA sequences were encoded by descriptors, which
substitute each nucleotide or amino acid with a numeri-
cal value [6]. Some examples of descriptors are hydro-
phobicity, molecular weight or isoelectric point. Other
studies represent a sequence by its mutations compared
to the wild type sequence [7]. Yet another possible
representation is the use of the standard orthonormal
representation [8] or sparse encoding [9], a vector con-
taining twenty indicator variables (one for each amino
acid) for each sequence position, resulting in a matrix
containing the amino acid distributions for each position
within the input sequence [10].
A drawback of conventional machine learning algo-
rithms is that they need a fixed input length, and, conse-
quently, cannot be easily applied to data which varies in
its dimension/length, as is often the case for protein
sequences. One possible remedy are SVMs with string
kernels [11,12]. Kernel functions return the inner pro-
duct between the mapped data points in a higher
dimensional space, and the special class of string kernels
tries to match alignments of subsequences to build a
higher dimensional feature space in which the sequences
can be separated [13]. Another possible solution is the
application of multiple sequence alignments [14] or
multiple pairwise alignments to a reference sequence
[15]. In these approaches, missing values are either filled
by a specifically defined value, or by the most common
value. However, this introduces some artificial informa-
tion that can bias predictions.
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more simple solution, that is to linearly normalize the
data to a fixed length as a preprocessing step and to
subsequently apply machine learning methods to classify
the data [16]. This interpolation procedure has already
been successfully applied to coreceptor usage prediction
in HIV-1 [17] and functional protein classification [18].
A particularly relevant application is in the prediction of
HIV-1 drug resistance. Anti-retroviral treatment regi-
mens can sufficiently suppress viral replication in HIV
infected patients and prevent the progression of the dis-
ease. One of the factors contributing to the progression
of the disease despite ongoing antiretroviral treatment is
the emergence of drug resistance: The high mutation
rate of HIV can lead to a fast adaptation of the virus
under drug pressure, thus to the evolution of drug-
resistant variants and failure of antiretroviral treatment.
Some of the resistant strains show insertions in the drug
targets HIV-1 protease and reverse transcriptase [19,20].
The focus of the current study is to compare the sim-
ple linear interpolation [16] with non-linear normaliza-
tion procedures in order to evaluate the performance in
subsequent classification. To this end, we tested seven
HIV protease inhibitors (PIs), six HIV nucleoside reverse
transcriptase inhibitors (NRTIs), three HIV nonnucleo-
side reverse transcriptase inhibitors (NNRTIs) and one
HIV maturation inhibitor (MI) datasets. PIs prevent
viral replication by inhibiting the activity of HIV-1 pro-
tease, an enzyme used by the viruses to cleave nascent
polypeptides into functional proteins. They are designed
to have a high affinity to the catalytic center of the HIV
protease, thereby hampering its enzymatic activity.
NRTIs and NNRTIs inhibit the activity of the reverse
transcriptase (RT). NRTIs are nucleoside analogs, and
thus, compete for the RT with the natural nucleosides.
An incorporation of a NRTI leads to a premature termi-
nation of the viral genome replication. In contrast,
NNRTIs are non-competitive inhibitors of the RT. They
inhibit the movement of protein domains of the RT that
is needed to carry out the process of DNA synthesis.
MIs, such as Bevirimat, inhibit maturation of virus parti-
cles by preventing cleavage of precursor polyprotein gag
by the HIV-1 protease.
Besides the comparison between the linear and non-
linear methods, we also compare our classification
results with results obtained from state-of-the-art meth-
ods. We focus on the comparison between our method
and other methods that employed exactly the same pub-
licly available datasets, namely Rhee et al. [7], Hou et al.
[21], Kierczak et al. [22] and Heider et al. [23].
Rhee et al. used five different statistical and machine
learning methods (DTs, ANNs, SVMs, least-squares
regression and least angle regression) to predict drug
resistance in HIV-1 [7] for 16 drugs. A sequence was
represented by its set of mutations compared to the
wild type sequence. Hou et al. developed a machine
learning approach for the prediction of PI resistance
based on SVMs [21], but in contrast to Rhee et al., they
used structure-derived descriptors. Kierczak et al. [22]
developed a set-based model considering physico-
chemical changes of mutated sequences compared to
the wildtype strain to predict NRTI and NNRTI resis-
tance. Heider et al. [23] used a multiple sequence align-
ment of the p2 sequences as an input for a RF to
predict Bevirimat resistance. Other published methods,
e.g. [24-26] employed other datasets, and hence, their
results cannot be easily compared with our method.
To check whether normalization is also advantageous
in other applications, we tested two datasets dealing
with protein functional class prediction [16,18], namely
the classification of small GTPases and the classification
of the major intrinsic protein family (MIP). Small
GTPases are small monomeric proteins that can act as
“molecular switches” due to their ability to bind and
hydrolyze GTP. In its GTP-bound form a small GTPase
is active, whereas a hydrolysis of GTP to GDP converts
the protein into its inactive conformation [27]. Small
GTPases are involved in many cellular processes includ-
ing differentiation, cell division, vesicular transport,
nuclear assembly, and control of the cytoskeleton. The
involvement of a variety of Ras superfamily proteins in
human tumorigenesis makes these proteins interesting
subjects in cancer research, and hence, the identification
and functional characterization of novel GTPases is an
important topic in molecular cell biology [28]. The
MIPs are a large family of different types of membrane
channels, e.g. aquaporines [29].
Results and discussion
The workflow applied in the current study is shown in
Figure 1. The sequences are encoded with the hydropa-
thy descriptor [30] and subsequently normalized to a
fixed length with the mentioned interpolation methods.
The normalized sequences are used to train the RF
model. We also tested the net charge, molecular weight
and isoelectric point as descriptors to encode the
sequences. The relative performance of each normaliza-
tion procedure in comparison to each other is quite
similar for all descriptors. However, the hydropathy
descriptor works best with regard to the prediction per-
formance, and thus we only show the results of the
hydropathy descriptor in the following.
HIV-1 protease and reverse transcriptase have rather
well conserved lengths of 99 and 240 amino acids,
respectively [7]. However, some of the protease and
reverse transcriptase sequences have insertions/deletions.
In constrast, sequence lengths of the GTPases and the
MIP datasets are highly variable (see Table 1) [16,23].
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Page 2 of 10Table 2 shows AUC values of the predictions,
Table 3 the results of the Wilcoxon Signed-Rank tests
(significance level a = 0.05). In the case of a maximal
(max) interpolation factor, the linear interpolation
method outperforms the other interpolation methods
in most of the datasets, except for 3TC, NVP and
BVM. Using the most frequent sequence length as
interpolation factor (most), the picture is less clear.
The linear interpolation works best for the datasets
ATV, AZT, ddI, TDF, DLV, EFV, GTP and MIP and
the fmm interpolation for the datasets NFV, RTV and
SQV. In most of the datasets max and most interpola-
tion do not perform significantly different according to
the Wilcoxon Signed-Rank tests.
Rhee et al. used five different statistical and machine
learning methods (DTs, ANNs, SVMs, least-squares
regression and least angle regression) to predict drug
resistance in HIV-1 [7]. In contrast to our encoding pro-
cedure, a sequence was represented by its set of muta-
tions compared to the wild type sequence. Hou et al.
developed a machine learning approach for the predic-
t i o no fP Ir e s i s t a n c e( A P V ,A T V ,I D V ,L P V ,N F V ,R T V
and SQV) based on SVMs [21], but in contrast to Rhee
et al., they used structure-derived descriptors. Their
method had a higher accuracy compared to the results
of Rhee et al. Table 4 shows a comparison of the pre-
diction accuracy for the best models of Rhee et al., Hou
et al. and the best model based on the methods used in
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Figure 1 Workflow of the applied procedure. The protein sequences are first encoded as vectors of numerical descriptor values, e.g. with the
hydropathy values of Kyte and Doolittle [30]. These vectors are normalized to a fixed length by applying the described interpolation methods.
Finally, the normalized encoded sequences are used as input for the random forests in the classification.
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Page 3 of 10the current study. Judged from the comparison of the
results, normalization of sequences seems in general to
improve classification performance, except for APV
(89% vs. 88% accuracy) and SQV (89% vs. 89% accu-
racy). However, we used the complete datasets whereas
the results of Rhee et al.a n dH o uet al.a r eb a s e do n
the best models for specific subsets, e.g. for APV they
report the results of the TSM subset (the best model of
Rhee et al. for the complete APV dataset reached only
an accuracy of 82%). For the NRTI and NNRTI datasets,
our procedure yielded higher accuracy compared to the
results from Rhee et al. for all datasets, except for 3TC
(90% vs. 90% accuracy) and for NVP (91% vs. 87% accu-
racy). As neither Rhee et al.n o rH o uet al.p r o v i d e d
standard deviations for the prediction accuracy, we can-
not perform a statistical comparison to warrant that our
results are significantly better for all datasets. To assess
the relative impact of normalization and actual machine
learning method, we also applied artificial neural net-
works in accordance to Rhee et al. The results are
worse compared to the results obtained with the RF
classification, but still better than the results of Rhee
et al., thus justifying sequence normalization as a pre-
processing step.
Kierczak et al. [22] provide AUC values with standard
deviations, so their results are directly comparable to
our results (see Table 5). Our results led to substantially
better results for the drugs ABC, d4T, DLV, NVP,
slighty better results for the drugs AZT and ddI and
slightly worse results for the drugs 3TC and TDF. Kierc-
zak et al. do not provide results for the drug EFV. Our
results show smaller standard deviations compared to
the results of Kierczak et al., which are based on a
rough set-based model [22]. For BVM resistance classifi-
cation, we obtained an AUC of 0.933 ± 0.002 with
machine learning on normalized sequences, which is
slightly, but significantly higher (according to Wilcoxon
Signed-Rank test at a = 0.05) than that (0.927 ± 0.001)
obtained with aligned sequences of the HIV-1 p2
sequences as input [23], thus again justifying sequence
normalization as a preprocessing step. The best AUCs
for the protein functional class prediction of the small
GTPases and the MIPs are 0.981 ± 0.001 and 0.827 ±
0.012, respectively, which are in accordance with our
recently published results [16,18].
As mentioned before, RFs are able to identify the
most important positions for the classification process
[31]. We studied importance of sequence positions for
each of our datasets. Five positions (L10, K20, I54,
V82, L90) in the HIV-1 protease are found in the top
ten list of most important mutations for the correct
classification of each protease inhibitor and two further
known mutations (M46, A71) are found in almost all
datasets (see Figure 2). Mutations at three positions -
L10, K20 and A71 - are known as compensatory, i.e.
compensating for the loss of enzyme activity due to
major protease mutations. These findings might be
explained by the origin of data from patients having
experienced multitherapy failures and thus developed
highly adapted viral strains. This would be in line with
the findings that protease inhibitor specific protease
mutations belong to the twenty most important posi-
tions for the classification process (APV: 32, 76; SQV:
48 and LPV: 76).
The ten most important resistance mutations of each
protease inhibitor (involving protease positions (50, 63,
73, 74, 76, 85 and 88)) are also in accordance with pre-
vious in vitro and in vivo findings (APV: 74 [32], LPV:
63 [33], ATV: 50 [34], NFV: 88 [35]).
The scoring of protease position 76 in terms of pre-
dicted ATV resistance is interesting, since it is well
known that protease mutation 76V, which confers resis-
tance to LPV and APV, re-sensitizes these HIV isolates
to the protease inhibitors SQV and ATV. Indeed, HIV
isolates carrying protease mutation 76 V accumulate in
the group of susceptible to ATV therapy regimens,
which therefore explains the prediction of susceptible
rather than resistant. This effect of re-sensitization has
been considered mainly in rule-based HIV drug resis-
tance interpretation tools, but has failed so far to reach
statistical significance in machine learning approaches.
Table 1 Summary of the datasets
dataset #
sequences
positive
samples
negative
samples
length
APV 768 61% 39% 99.70 ± 1.24%
ATV 329 48% 52% 99.59 ± 1.06%
IDV 827 51% 49% 99.68 ± 1.23%
LPV 517 45% 55% 99.73 ± 1.22%
NFV 844 40% 60% 99.67 ± 1.22%
RTV 795 49% 51% 99.71 ± 1.24%
SQV 826 60% 40% 99.69 ± 1.23%
3TC 633 31% 69% 240.87 ± 2.33%
ABC 628 29% 71% 240.54 ± 4.20%
AZT 630 52% 48% 240.87 ± 2.33%
d4T 630 54% 46% 240.54 ± 4.20%
ddI 632 49% 51% 240.87 ± 2.33%
TDF 353 67% 33% 240.72 ± 1.88%
DLV 732 64% 36% 241.28 ± 1.49%
EFV 734 62% 38% 241.32 ± 1.49%
NVP 746 57% 43% 241.30 ± 1.48%
BVM 155 28% 72% 20.77 ± 2.07%
GTP 1435 46% 54% 232.18 ± 22.37%
MIP 49 39% 61% 261.41 ± 21.47%
The table summarizes number of sequences within each dataset, percentages
of positive and negative samples, average lengths ± standard deviations in
percent.
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major known resistant mutations such as M41, L74,
M184, L210 and K219 [36].
The normalization of the sequence length for the pre-
diction of drug resistance allows to analyze HIV pro-
tease sequences carrying insertions/deletions. Insertions
in the protease are sometimes observed in HIV isolates
failing PI therapies. It has been shown in a recent study
[20] that the prevalence of insertions has increased sig-
nificantly in the last years. Furthermore, it has been
shown in an earlier study [19] that RT insertions are
frequently found in heavily-treated patients, which can
enhance NRTI resistance and may improve viral fitness.
Our classification procedure is able to classify these
recently published protease and reverse transcriptase
insertions in terms of resistance correctly.
Conclusions
In most of the cases studied here, linear interpolation
gave superior AUC values in comparison with non-lin-
ear schemes. In some cases, other interpolation methods
lead to slightly, but significantly higher AUCs, e.g. for
Table 2 Prediction results
Drug linear max most splines max most fmm max most periodic max most natural max most
APV 0.934 ± 0.001 0.929 ± 0.002 0.928 ± 0.001 0.927 ± 0.001 0.928 ± 0.001
0.932 ± 0.001 0.934 ± 0.001 0.932 ± 0.002 0.933 ± 0.001 0.933 ± 0.001
ATV 0.936 ± 0.002 0.917 ± 0.003 0.920 ± 0.002 0.919 ± 0.002 0.920 ± 0.002
0.928 ± 0.002 0.915 ± 0.003 0.919 ± 0.003 0.918 ± 0.003 0.920 ± 0.003
IDV 0.972 ± 0.001 0.968 ± 0.001 0.968 ± 0.001 0.968 ± 0.001 0.968 ± 0.001
0.970 ± 0.001 0.970 ± 0.001 0.971 ± 0.001 0.971 ± 0.001 0.972 ± 0.001
LPV 0.964 ± 0.001 0.963 ± 0.001 0.963 ± 0.001 0.962 ± 0.001 0.963 ± 0.001
0.963 ± 0.001 0.964 ± 0.001 0.963 ± 0.001 0.963 ± 0.001 0.964 ± 0.001
NFV 0.941 ± 0.001 0.938 ± 0.001 0.940 ± 0.001 0.940 ± 0.001 0.940 ± 0.001
0.939 ± 0.001 0.943 ± 0.001 0.947 ± 0.001 0.946 ± 0.001 0.945 ± 0.001
RTV 0.984 ± 0.001 0.980 ± 0.001 0.981 ± 0.001 0.981 ± 0.001 0.981 ± 0.001
0.983 ± 0.001 0.986 ± 0.001 0.986 ± 0.001 0.986 ± 0.001 0.986 ± 0.001
SQV 0.955 ± 0.001 0.950 ± 0.001 0.951 ± 0.001 0.951 ± 0.001 0.951 ± 0.001
0.952 ± 0.001 0.953 ± 0.001 0.957 ± 0.001 0.955 ± 0.001 0.956 ± 0.001
3TC 0.933 ± 0.002 0.936 ± 0.002 0.939 ± 0.002 0.938 ± 0.002 0.939 ± 0.002
0.927 ± 0.003 0.934 ± 0.002 0.937 ± 0.002 0.937 ± 0.002 0.937 ± 0.003
ABC 0.916 ± 0.002 0.906 ± 0.002 0.909 ± 0.003 0.909 ± 0.002 0.909 ± 0.002
0.914 ± 0.003 0.910 ± 0.003 0.918 ± 0.003 0.919 ± 0.002 0.918 ± 0.003
AZT 0.908 ± 0.002 0.890 ± 0.002 0.894 ± 0.002 0.893 ± 0.002 0.894 ± 0.002
0.908 ± 0.002 0.898 ± 0.002 0.905 ± 0.002 0.903 ± 0.002 0.904 ± 0.002
d4T 0.903 ± 0.002 0.886 ± 0.002 0.889 ± 0.002 0.889 ± 0.002 0.889 ± 0.002
0.900 ± 0.002 0.892 ± 0.002 0.901 ± 0.002 0.899 ± 0.002 0.901 ± 0.002
ddI 0.853 ± 0.003 0.829 ± 0.003 0.837 ± 0.003 0.836 ± 0.003 0.836 ± 0.002
0.852 ± 0.003 0.841 ± 0.003 0.846 ± 0.003 0.839 ± 0.003 0.844 ± 0.003
TDF 0.832 ± 0.004 0.808 ± 0.005 0.817 ± 0.004 0.818 ± 0.005 0.816 ± 0.005
0.825 ± 0.005 0.812 ± 0.005 0.813 ± 0.005 0.814 ± 0.005 0.813 ± 0.005
DLV 0.901 ± 0.002 0.888 ± 0.002 0.891 ± 0.002 0.891 ± 0.002 0.891 ± 0.002
0.898 ± 0.002 0.881 ± 0.002 0.882 ± 0.002 0.883 ± 0.002 0.883 ± 0.002
EFV 0.932 ± 0.002 0.921 ± 0.002 0.928 ± 0.002 0.929 ± 0.002 0.928 ± 0.002
0.925 ± 0.002 0.911 ± 0.002 0.915 ± 0.002 0.919 ± 0.002 0.915 ± 0.002
NVP 0.917 ± 0.002 0.910 ± 0.002 0.916 ± 0.002 0.917 ± 0.002 0.916 ± 0.002
0.908 ± 0.003 0.902 ± 0.003 0.906 ± 0.003 0.909 ± 0.003 0.906 ± 0.003
BVM 0.918 ± 0.002 0.932 ± 0.002 0.932 ± 0.002 0.923 ± 0.003 0.933 ± 0.002
GTP 0.981 ± 0.001 0.979 ± 0.001 0.978 ± 0.001 0.977 ± 0.001 0.979 ± 0.001
0.980 ± 0.001 0.979 ± 0.001 0.979 ± 0.001 0.976 ± 0.001 0.979 ± 0.001
MIP 0.815 ± 0.010 0.789 ± 0.013 0.789 ± 0.011 0.787 ± 0.016 0.788 ± 0.017
0.827 ± 0.012 0.815 ± 0.014 0.813 ± 0.014 0.816 ± 0.013 0.812 ± 0.013
AUC ± standard deviations with max representing the maximal occuring sequence length within a dataset, most the most frequent sequence length in a dataset.
For BVM most and max are the same.
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sequence lengths in combination with hydropathy as a
descriptor and RFs led to at least competitive results
compared to other methods [7,21-23]. Although
sequence length variations are rare in the case of HIV-1
protease and reverse transcriptase, there are some inser-
tions and deletions known, and these can be handled
consistently with the proposed procedure. Our method
is able to correctly predict drug resistance in HIV-1 iso-
lates carrying insertions in the protease [20]. Moreover,
the GTPases and the MIP datasets show a high
sequence variability, which can be easily handled with
our proposed scheme. As demonstrated, there is no sig-
nificant performance difference between the most and
the max interpolation. Finally, the proposed normaliza-
tion procedure based on a simple linear interpolation is
not limited to studies dealing with HIV-1 drug
resistance or classification of small GTPases. Other
applications may address e.g. protein-protein interaction
prediction [37,38], prediction of protein cellular attri-
butes [39], protein localization prediction [40] and pro-
tein remote homology detection [41]. The current study
provides evidence for the reliability of the simple linear
interpolation for handling varying protein sequence
lengths in a broader range of biomedical classification
studies.
Methods
Data
The data was gathered from two classification studies of
HIV-1 drug resistance and two protein functional class
prediction studies [7,16,23]. We analyzed the drug target
protein sequences for resistance (= negative) or suscept-
ibility (= positive) to the corresponding drugs. These
drugs include seven protease inhibitors (PIs) Amprena-
vir (APV), Atazanavir (ATV), Indinavir (IDV), Lopinavir
(LPV), Nelfinavir (NFV), Ritonavir (RTV), Saquinavir
(SQV), the six nucleoside reverse transcriptase inhibitors
(NRTIs) Lamivudine (3TC), Abacavir (ABC), Zidovudine
(AZT), Stavudine (d4T), Didanosine (ddI), Tenofovir
Table 3 Wilcoxon Signed-Rank tests
method APV ATV IDV LPV NFV RTV SQV 3TC ABC AZT D4T DDI TDF DLV EFV NVP BVM GTP MIP
linear * * * * * * * * * * * * * * * * * *
splines
fmm * *
periodic * *
natural * *
linear * * * * * * * * * * *
splines
fmm * * * * * * *
periodic * * *
natural * * * * * *
Wilcoxon Signed-Rank tests on the AUC distributions. The method performing best and having significantly higher AUC values (a = 0.05) is marked with *. When
a test is not significant more than one method is marked. The upper part shows the result of the max-interpolation, the lower part the results of the most-
interpolation.
Table 4 Comparison of the prediction accuracy
drug Rhee et al. Hou et al. this study
APV 84% 89% 88%
ATV 77% 86% 88%
IDV 79% 86% 93%
LPV 81% 91% 92%
NFV 82% 87% 91%
RTV 89% 93% 95%
SQV 84% 89% 89%
3TC 90% * 90%
ABC 77% * 88%
AZT 76% * 84%
d4T 78% * 84%
ddI 75% * 79%
TDF 73% * 79%
DLV 84% * 87%
EFV 87% * 88%
NVP 91% * 87%
*: Hou et al. used only the PI datasets [21].
Table 5 AUC comparison
drug Kierczak et al. this study
3TC 0.95 ± 0.03 0.94 ± 0.00
ABC 0.83 ± 0.05 0.92 ± 0.00
AZT 0.89 ± 0.05 0.91 ± 0.00
d4T 0.85 ± 0.06 0.90 ± 0.00
ddI 0.82 ± 0.08 0.85 ± 0.00
TDF 0.85 ± 0.05 0.83 ± 0.00
DLV 0.76 ± 0.06 0.90 ± 0.00
EFV * 0.93 ± 0.00
NVP 0.85 ± 0.05 0.92 ± 0.00
AUC ± standard deviations.
*: Kierczak et al. analyzed the NRTI and NNRTI datasets except EFV [22].
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inhibitors (NNRTIs) Delavirdine (DLV), Efavirenz (EFV),
Nevirapine (NVP) and the maturation inhibitor Beviri-
mat (BVM). Furthermore, we analyzed protein
sequences for membership or non-membership in the
functional class of small GTPases and MIP, respectively.
These datasets contained protein sequences belonging
to the specific family (= positive) and proteins that do
not belong to the family (= negative) [16]. Table 1
shows a summary of the datasets used in the current
study. The ratio of the positive to the negative class is at
least 1:3 (except for ABC, 3TC and BVM). The cut-offs
of the IC50 values between susceptible and resistant
sequences are in accordance with Rhee et al.[ 7 ]a n d
Heider et al. [23].
Descriptor set
It has been shown to be helpful to associate with each
amino acid a numerical “descriptor” value, for instance a
value that captures a physico-chemical property of this
amino acid, instead of treating sequences of amino acids
as strings of characters. The selection of the descriptor
set is the most critical part in classification [6,42], and,
in general, physico-chemical descriptors outperform
simpler descriptors [43]. In particular the hydropathy
index of Kyte and Doolittle [30] has proven in several
studies to be a powerful descriptor [44-48]. Therefore,
we used this index to encode the amino acids in the
protein sequences. Moreover, we also tested net charge,
molecular weight and isoelectric point as descriptors for
encoding of the amino acids.
Normalization procedures
The HIV-1 protease (PR) sequences, the HIV-1 reverse
transcriptase (RT) sequences, the HIV-1 p2 sequences
and the protein sequences for functional classification
were normalized to the maximally (max) occurring
s e q u e n c el e n g t h sa sw e l la st ot h em o s tf r e q u e n t
sequence lengths (most). We used five different normali-
zation procedures, the simple linear interpolation and
four spline interpolations implemented in different
R-packages (http://www.r-project.org/):
￿ simple linear interpolation (linear)
￿ cubic spline interpolation (splines)
￿ spline interpolation of Forsythe [49] (fmm)
￿ periodic spline interpolation (periodic)
￿ natural spline interpolation (natural)
The linear interpolation connects two known data
points, (x0, y0)a n d( x1, y1), with a straight line. xi indi-
cates the sequence position and yi indicates the corre-
sponding value of the amino acid at position xi.T h ey
value of a value × in the interval [x0, x1]i sg i v e nb y
y = y0 + (x − x0)
y1 − y0
x1 − x0
. (1)
Linear interpolation on a set of data points (x0, y0),
(x1, y1),..., (xn, yn) is defined as the concatenation of lin-
ear interpolants between each pair of successive data
points. The cubic spline interpolation uses piecewise
cubic polynomials between the data points. The spline
interpolation of Forsythe [49] is a variant of cubic spline
interpolation with the cubic passing exactly through the
four points at each end of a sample (here: the four
encoded amino acids at each end of a protein). The per-
iodic spline interpolation fits a curve that fulfills peri-
odic boundary conditions, i.e. the spline curve has the
same first and second derivative at its endpoints. For
the natural spline interpolation, the natural boundary
conditions are fulfilled. All interpolation methods result
in continuous curves connecting all known data points.
However, the progressions of the curves differ from
each other.
The normalization factor is defined as the number of
samples taken (by equal interval) from the aforemen-
tioned curves to generate an input for the subsequent
classification. In Figure 3 the application of the simple
linear interpolation from 8 to 15 values is demonstrated
with a fictitious descriptor mapping the twenty amino
acids to numerical values between -1 and 1. Starting
with sequence s = PLAIRNIQ the descriptor encodes s
    1        10        20        30        40        50        60        70        80        90
APV: PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
ATV: PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
IDV: PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
LPV: PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
NFV: PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
RTV: PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
SQV: PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
Figure 2 Most important sequence positions for the PI classification. Sequences of HIV-1 protease with the ten most important positions
marked in gray.
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Page 7 of 10into the vector ˜ s = (1.00, 0.81, 0.00, 0.82, - 0.37, - 0.28, 0.82, 0.9). Apply-
ing the simple linear interpolation with a normalization
factor n = 15 results in the interpolated vector
˜ s15 = (1.00, 0.91, 0.81, 0.41, 0.00, 0.41, 0.82, 0.23, - 0.37, - 0.33, - 0.28, 0.27, 0.82, 0.86, 0.9).
A fragment of the R-code for creating a Forsythe inter-
polation is shown here:
# for all samples in the data set
for(i in 1:number_of_samples) {
y = data[i,] # pick
sequence i
x = seq(1:length(y))
f = splinefun(x,y, method="fmm”)#
create interpolation function f
stepsize = length(y)/normalization_-
factor # new stepsize
x.new = c() # new
resulting × values
for(n in 1:normalization_factor){
x.new = c(x.new, n*stepsize)
}
y.new = f(x.new) # calcu-
lation of new y values
data.new = cbind(data.new, y.new) #
adding new sample to the new dataset
}
Classification
We trained random forests (RF) [31] as implemented in
the R package randomForest (http://www.r-project.org/)
for the classification. Earlier studies have shown that
RFs are excellent non-linear classifier, which are highly
stable and robust in comparison to other classifiers [50].
They consist of a set of independent decision trees
whose outputs are combined to generate a final deci-
sion. In our application, each RF consisted of 2000 ran-
domly and independently grown decision trees. When
using the trained RF for prediction, an unseen sequence
w a sa s s i g n e dt ot h ec l a s sv o t e df o rb ya tl e a s t5 0 %o f
the trees.
RFs provide an importance analysis, which can be
used to identify the most important positions for the
classification process. The importance measures the
decrease in prediction accuracy, when the corresponding
variable is permuted [31]. As the importance measure
might be affected by correlated positions [51], we calcu-
lated the pairwise correlation of each sequence position
with each other position. It turned out that the impor-
tance measurement is not affected by correlation.
Cross-validation
The RFs were validated using 100-fold leave-one-out
[52] validation to evaluate the average prediction sensi-
tivity, specificity, and accuracy (see formulas below) and
the ability to generalize to unseen sequences. The sensi-
tivity, specificity, and accuracy were calculated according
to:
sensitivity =
TP
TP + FN
(2)
speciﬁcity =
TN
TN + FP
(3)
accuracy =
TP + TN
TP + TN + FP + FN
(4)
with true positives TP, false positives FP,f a l s en e g a -
tives FN and true negatives TN. Furthermore, we calcu-
lated the Receiver Operating Characteristics (ROC)
curve [53] and the corresponding area under the curve
(AUC) with ROCR [54]. The ROC curve is built by plot-
ting sensitivity and specificity against each other for
every possible cut-off between the two classes.
Statistical comparison
All interpolation procedures were compared by applying
Wilcoxon Signed-Rank tests [55] on the AUC distributions
from the 100-fold leave-one-out cross-validation runs
according to Demsar [56]. The null hypothesis was that
there are no differences between the compared classifiers.
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